Dr. Feldman paints a ”then vs. now”’ picture of progress over the past 35 years, when JM care was fragmented and inconsistent, versus today’s coordinated approach. He discusses how these efforts are helping bring clinical trials from the research bench to the clinic exam room faster and accelerating real-world improvements for kids and families living with this rare disease.
Dr. Brian Feldman is chair of Cure JM’s Medical Advisory Board and a global leader in pediatric rheumatology. Based at the Hospital for Sick Children and the University of Toronto, Dr. Feldman is internationally recognized for his contributions to clinical research and care delivery in childhood autoimmune diseases.
